Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: Application to melanoma vaccine development

Gene Therapy

Volumn 4, Issue 10, 1997, Pages 1061-1068

  Wiznerowicz, M ^a   Fong, A Z C ^b   Mackiewicz, A ^a   Hawley, R G ^b  

^a Greatpoland Cancer Center   (Poland)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cancer gene therapy; IL 6; Melanoma; MSCV; nlslacZ; retroviral vector; Soluble IL 6 receptor

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MELANOMA VACCINE; NEOMYCIN; PHOSPHOTRANSFERASE;

ARTICLE; CANCER CELL CULTURE; CISTRON; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MELANOMA; PRIORITY JOURNAL; PROMOTER REGION; RECOMBINANT GENE; REPORTER GENE; RETROVIRUS;

HUMAN HERPESVIRUS 5; UNIDENTIFIED RETROVIRUS;

EID: 0030782130     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300500     Document Type: Article

References (59)

1. Nanda NK, Sercarz EE. Induction of anti-self-immunity to cure cancer. Cell 1995; 82: 13-17.
2. Pardoll DM. Paracrine cytokine adjuvants in cancer immunotherapy. Ann Rev Immunol 1995; 13: 399-415.
3. Dranoff G et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
4. Jaffee EM et al. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 1993; 53: 2221-2226.
5. Vile RG, Russell SJ. Gene transfer technologies for the gene therapy of cancer. Gene Therapy 1994; 1: 88-98.
6. Tahara H et al. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts. Hum Gene Ther 1995; 6: 1607-1624.
7. Livingston PO et al. The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines. Cancer 1985; 56: 2194-2200.
8. Mackiewicz A et al. Gene therapy of human melanoma: immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptor. Hum Gene Ther 1995; 6: 805-811.
9. Knight BC et al. Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine. Melanoma Res 1996; 6: 299-306.
10. Mackiewicz A et al. Immuno-gene therapy of malignant melanoma: phase I/II trial. Hum Gene Ther (Submitted for publication).
11. Coulie PG. Antigens recognized on human tumors by cytolytic T lymphocytes: towards vaccination? Stem Cells 1995; 13: 393-403.
12. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Meth Enzymol 1993; 217: 581-599.
13. Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-932.
14. Hawley RG. Therapeutic potential of retroviral vectors. Transfus Sci 1996; 17: 7-14.
15. Grez M, Akgün E, Hilberg F, Ostertag W. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci USA 1990; 87: 9202-9206.
16. Berwin B, Barklis E. Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations. Nucleic Acids Res 1993; 21: 2399-2407.
17. Palmer TD, Rosman GJ, Osborne WRA, Miller AD. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 1991; 88: 1330-1334.
18. Challita P-M, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 1994; 91: 2567-2571.
19. Emerman M, Temin HM. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 1984; 39: 459-467.
20. Lupton SD, Brunton LL, Kalberg VA, Overell RW. Dominant positive and negative selection using a hygromycin phospho-transferase-thymidine kinase fusion gene. Mol Cell Biol 1991; 11: 3374-3378.
21. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 1991; 11: 5848-5859.
22. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989; 7: 980-990.
23. Hawley RG, Sabourin LA, Hawley TS. An improved retroviral vector for gene transfer into undifferentiated cells. Nucleic Acids Res 1989; 17: 4001.
24. Hawley RG, Fong AZC, Burns BF, Hawley TS. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 1992; 176: 1149-1163.
25. Hawley RG. Hematopathology of interleukin-6-type cytokines. Stem Cells 1994; 12 (Suppl. 1): 155-171.
26. Hawley RG et al. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin-11. Proc Natl Acad Sci USA 1996; 93: 10297-10302.
27. Hawley RG, Lieu FHL, Fong AZC, Hawley TS. Versatile retroviral vectors for potential use in gene therapy. Gene Therapy 1994; 1: 136-138.
28. Conneally E et al. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retrovirus-mediated gene transfer. Blood 1996; 87: 456-464.
29. Lu M et al. Retrovirus-mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation. Hum Gene Ther 1996; 7: 2263-2271.
30. Cheng L et al. A GFP reporter system to assess gene transfer and expression in viable human hematopoietic progenitors. Gene Therapy (in press).
31. Lai C-F et al. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J Biol Chem 1996; 271: 13968-13975.
32. Wang Y et al. Leptin receptor action in hepatic cells. J Biol Chem 1997; 272: 16216-16223.
33. Ferry N et al. Retrovirus-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA 1991; 88: 8377-6381.
34. Treisman J et al. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. Blood 1995; 85: 139-145.
35. Hantzopoulos PA, Sullenger BA, Ungers G, Gilboa E. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc Natl Acad Sci USA 1989; 86: 3519-3523.
36. Rittner K, Stoppler H, Pawlita M, Sczakiel G. Versatile eucaryotic vectors for strong and constitutive transient and stable gene expression. Meth Mol Cell Biol 1991; 2: 176-181.
37. Hawley RG et al. Retroviral vectors for production of interleukin-12 in the bone marrow to induce a graft-versus-leukemia effect. Ann NY Acad Sci 1996; 795: 341-345.
38. Mackiewicz A et al. Soluble interleukin 6 receptor is biologically active in vivo. Cytokine 1995; 7: 142-149.
39. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 1992; 149: 2021-2027.
40. Hock RA, Miller AD, Osborne WR. Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines. Blood 1989; 74: 876-881.
41. Chen L, Perlick H, Morgan RA. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX. Hum Gene Ther 1997; 8: 125-135.
42. Adam MA, Osborne WRA, Miller AD. R-region cDNA inserts in retroviral vectors are compatible with virus replication and high-level protein synthesis from the insert. Hum Gene Ther 1995; 6: 1169-1176.
43. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-926.
44. Aebischer P et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med 1996; 2: 696-699.
45. Vile R, Miller N, Chernajovsky Y, Hart I A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes. Gene Therapy 1994; 1: 307-316.
46. Ferrari G et al. A retroviral vector containing a muscle-specific enhancer drives expression only in differentiated muscle fibers. Hum Gene Ther 1995; 6: 733-742.
47. Lieu FHL, Hawley TS, Fong AZC, Hawley RG. Transmissibility of MSCV-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy. Cancer Gene Ther 1997; 4: 167-175.
48. Gansbacher B et al. Retroviral gene transfer induced constitutive expression of IL-2 or IFN-γ in irradiated human melanoma cells. Blood 1992; 80: 2817-2822.
49. Gansbacher B et al. Clinical protocol: a pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma. Hum Gene Ther 1992; 3: 677-690.
50. Mule JJ, McIntosh JK, Jablons DM, Rosenberg SA. Antitumor activity of recombinant interleukin 6 in mice. J Exp Med 1990; 171: 629-636.
51. Sun WH, Kreisle A, Philips AW, Ershler WB. In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. Cancer Res 1992; 52: 5412-5415.
52. Taga T et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573-581.
53. Gajewski TF, Renauld J-C, Van Pel A, Boon T. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine cytolytic T lymphocytes in vitro. J Immunol 1995; 154: 5637-5648.
54. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990; 8: 253-278.
55. Herlyn M. Human melanoma: development and progression. Cancer Metas Rev 1990; 9: 101-112.
56. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6: 2895-2902.
57. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
58. Sanes JR, Rubenstein JLR, Nicolas J-F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 1986; 5: 3133-3142.
59. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.